September 10, 2024 by Diabetologia Credit: Lukas from PexelsThe obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), and published simultaneously in the New England Journal of...
by University of Cincinnati Credit: Unsplash/CC0 Public DomainA clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE found a drug was safe and effective for weight loss for patients with stable bipolar disorder. The trial results were published in the Journal of Clinical Psychopharmacology. Susan McElroy, MD, study primary investigator, said...
by Vanderbilt University Medical Center Graphical abstract. Credit: Diabetes (2023). DOI: 10.2337/db23-0356A recent study published in the journal Diabetes demonstrates that a glucagon-like peptide-1 receptor (GLP-1R) agonist, a member of a class of medication used to treat type 2 diabetes and obesity, can lead to a rapid improvement in insulin sensitivity. Insulin sensitivity is how responsive...
The GLP-1 agonist liraglutide (Victoza, Novo Nordisk) was the overall winner compared with three other diverse agents for treating patients with type 2 diabetes already maintained on metformin. But while liraglutide performed better than insulin glargine, sitagliptin, and glimepiride, the randomized, multicenter study of 5047 patients fell short of being the last word. In part, that’s because the study was devoid of a...
THE ENDOCRINE SOCIETY WASHINGTON–Liraglutide 3.0 mg, approved by the United States Food and Drug Administration (FDA) as an adjunct to a reduced-calorie diet and increased physical activity to help adults with obesity manage their weight, appears to help adolescents too, according to an industry-sponsored randomized controlled trial. The study was accepted for presentation at ENDO...
TORONTO, August 27, 2018 – A drug used to manage diabetes may reduce heart disease and death in people with diabetes regardless of their cholesterol levels and whether they are on a statin therapy, suggests a new analysis of the LEADER trial. IMAGE: A DRUG USED TO MANAGE DIABETES MAY REDUCE HEART DISEASE AND DEATH IN...
